文献速递生殖医学

第5天慢速生长胚胎新鲜移植与第6天完全扩张囊胚玻璃化冷冻后延迟移植:哪种方案最优?

Fresh transfer of Day 5 slow-growing embryos versus deferred transfer of vitrified, fully expanded Day 6 blastocysts: which is the optimal approach?
PubMed 文献 · Hum Reprod · 2019-01-01

回顾性研究纳入477例<40岁女性,比较第5天慢速生长胚胎新鲜单胚胎移植与后续冻融周期移植第6天完全扩张囊胚的结局。第5天开始囊胚化的胚胎新鲜移植与冻融移植临床妊娠率和活产率无显著差异;仅见桑葚胚者新鲜移植的临床妊娠率和活产率显著低于冻融移植。

要点

  • 第5天开始囊胚化者,新鲜移植与冻融移植临床妊娠率31.0% vs 30.4%(P=0.86),无显著差异。
  • 第5天仅见桑葚胚者,新鲜移植临床妊娠率5.3% vs 冻融移植30.1%(P<0.001)。
  • 第5天仅见桑葚胚者,新鲜移植活产率1.8% vs 冻融移植20.5%(P<0.001)。

核心结论

  • 第5天开始囊胚化的胚胎,新鲜移植与同一队列来源的完全扩张囊胚冻融移植结局相似。
  • 第5天仅见桑葚胚/致密化胚胎时,延长培养至完全扩张囊胚后行冻融移植可获得显著更高的活产率。

研究设计与样本

  • 回顾性研究,纳入2012至2016年间477例<40岁女性,均行第5天慢速生长胚胎新鲜单胚胎移植及后续同一IVF周期的完全扩张囊胚冻融移植。
  • 共纳入1070个胚胎移植周期(新鲜+冻融):365例女性行第5天慢速生长囊胚新鲜单胚胎移植(I组),112例行第5天桑葚胚新鲜单胚胎移植(II组)。
  • I组和II组分别进行457个和136个后续冻融移植周期。

主要发现

  • I组平均年龄33.8±2.9岁,第5天胚胎至第6天发育为完全扩张囊胚的比例为92%,玻璃化冷冻囊胚数627个(平均每周期1.71个)。
  • I组新鲜移植与冻融移植的临床妊娠率31.0% vs 30.4%(P=0.86),活产率23.3% vs 20.3%(P=0.15),均无显著差异。
  • II组平均年龄35.8±3.4岁,桑葚胚至第6天发育为完全扩张囊胚的比例为72%,第6天玻璃化冷冻囊胚数155个(平均每周期1.38个)。
  • II组新鲜移植的临床妊娠率显著低于冻融移植(5.3% vs 30.1%,P<0.001),活产率亦显著降低(1.8% vs 20.5%,P<0.001)。
  • 控制可能混杂因素后结果不变。

局限性

  • 回顾性设计是本研究的主要局限性。
  • 尽管比较的是同一队列来源的胚胎,冻融移植周期可能过度代表了年龄较大和预后较差的患者。
  • 研究仅纳入第6天有可供冷冻囊胚的周期,因此结果不适用于必须第5天移植且无胚胎可玻璃化冷冻者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: In IVF cycles in which the entire embryo cohort is slow growing, is it optimal to perform fresh transfer in Day 5 or to extend the culture and transfer in subsequent vitrified-warmed cycles? SUMMARY ANSWER: The outcomes depend on the degree of embryo development on Day 5. WHAT IS KNOWN ALREADY: Slow-growing blastocysts have lower implantation potential when transferred in fresh cycles. It has been suggested that embryo-endometrial asynchrony could explain this finding. However, studies that compared Days 5 and 6 embryos in frozen embryo transfer (FET) cycles showed contradictory results. There is still a lack of evidence regarding the best approach, performing fresh transfer or deferring transfer and continuing culture until fully developed blastocysts are achieved, when the entire cohort of embryos is slow growing. STUDY DESIGN SIZE, DURATION: This was a retrospective study that included 477 women aged <40 years who underwent fresh Day 5 single embryo transfer of slow-growing embryos and subsequent FET cycles of fully expanded blastocysts (FEB) originating from the same IVF cycle between 2012 and 2016. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study included cycles in which the embryos either began blastulation by Day 5 of culture but did not reach the fully expanded stage (Gardner Stage III) or had delayed blastulation with only morula embryos present by Day 5 of culture. All of the subjects in the study underwent elective, single embryo transfer (slow or delayed blastocysts) on Day 5 and had at least one embryo that developed into a FEB on extended culture Day 6 that was suitable for vitrification. All subjects, regardless of the outcome of the fresh transfer, returned for at least one subsequent FET cycle of Day 6 embryos. MAIN RESULTS AND ROLE OF CHANCE: A total of 1070 embryo transfer cycles (fresh + FET) were included. Of them, 365 women had elective, fresh, single transfer of slow-growing blastocysts (Group I) and 112 had elective, fresh, single morula transfer (Group II). Groups I and II underwent a subsequent 457 and 136 FET cycles, respectively. The mean age of Group I was 33.8 ± 2.9 years, the proportion of Day 5 embryos that developed to FEB by Day 6 was 92%, and the number of blastocysts vitrified was 627 (average of 1.71 blastocysts per cycle). The outcomes of fresh and FET cycles were comparable regarding clinical pregnancy rate (CPR) (31.0 vs. 30.4%, P = 0.86) and live birth rate (LBR) (23.3 vs. 20.3%, P = 0.15). In Group II, the mean age was 35.8 ± 3.4 years and the proportion of morula embryos that developed to FEB by Day 6 was 72%. The number of blastocysts vitrified on Day 6 was 155 (1.38 per cycle). The transfer of fresh embryos in Group II resulted in significantly lower clinical pregnancy (5.3 vs. 30.1%, P < 0.001) and LBRs (1.8 vs. 20.5%, P < 0.001). The results did not change after controlling for possible confounding factors. LIMITATIONS AND REASONS FOR CAUTION: The retrospective design of the study is a major limitation. Although we compared the outcomes of embryos that originated from the same cohort, the FET cycles could have been overrepresented by older patients and those with poorer prognoses. Furthermore, the study included only cycles in which there were blastocysts available for cryopreservation on Day 6; therefore, the results were not be applicable for those who had mandatory Day 5 transfer with no embryos available for vitrification. WIDER IMPLICATIONS OF THE FINDINGS: Fresh transfer of embryos that begin blastulation on Day 5 results in similar outcomes to the transfer of FEB originating from the same cohort. However, in cases where only morula/compacting embryos are available by Day 5, extending culture until FEB are achieved and then performing subsequent FET will result in significantly higher LBRs. STUDY FUNDING/COMPETING INTEREST(S): No external funding was used for this study. The authors have no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Tannus S, Cohen Y, Henderson S, et al. Fresh transfer of Day 5 slow-growing embryos versus deferred transfer of vitrified, fully expanded Day 6 blastocysts: which is the optimal approach? Hum Reprod. 2019. PMID: 30517719. doi:10.1093/humrep/dey351

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。